Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic has become a huge health emergency, with Italy being one of the most heavily affected countries. Cancer patients (pts), especially those with lung cancer (LC), represent a very frail population, and multiple efforts need to be taken by Oncology Departments to guarantee diagnostic-therapeutic pathways (DTP). Aim of this multicenter Italian study is to assess whether the COVID-19 outbreak impacted the LC pts’ likelihood of receiving timely diagnosis and access to treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
